To investigate whether BRD4 activation in ovarian cancer cells correlates with CSF1 expression, the number of TAMs in human ovarian tumors, and patient prognosis, we examined the p-BRD4 and CSF1 levels in tumor cells and the number of TAMs using peritoneal implantation metastasis tissues from 128 human ovarian cancer (OC) patients with treatment and survival information29. This evidence concerns the gene BRD4 and neoplasm.